This paper provides evidence that ITF2357 is particularly efficacious in inducing melanoma cell death and demonstrates for the first time that it is capable of targeting oncogenic BRAF and overcoming pro-survival autophagy, laying the foundations for translational studies and possible new melanoma-targeted therapy. This evidence concerns the gene BRAF and melanoma.